AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from the CDSCO, ...

In a regulatory filing, the company said it has received permission from the Central Drugs Standard Control Organisation ...

The Central Drugs Standard Control Organisation granted approval for the drug's use in combination with Durvalumab for the ...

This approval establishes the use of Olaparib in combination with Durvalumab as a maintenance treatment for adult patients ...

Olaparib in combination with Durvalumab is indicated for the maintenance treatment of adult patients with advanced or ...

AstraZeneca Pharma India has received approval from the CDSCO for Olaparib film-coated tablets, set to launch in India for ...

AstraZeneca Pharma India has gained approval from India's drug regulator to import cancer treatment drug Lynparza for sale. The tablets are for use in combination therapy for patients with specific ...

Bangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from ...

AstraZeneca Pharma India Ltd. has received approval from CDSCO to import and sell Lynparza (Olaparib) in India. Lynparza will ...

In a regulatory filing, the company said it has received permission from the Central Drugs Standard Control Organisation ...

In a filing with the exchanges, AstraZeneca Pharma said that it had received permission from the CDSCO to import, sell, and ...

For the first time in 30 years, a drug used to treat endometriosis will be listed on the pharmaceutical benefits scheme.